The North Carolina Immunization Program (NCIP) would like to inform you of two new updates to the coverage criteria:
1.) The 317 Vaccines for Adults (VFA) coverage criteria has been expanded to include the HPV (GARDASIL®9) vaccine for uninsured and underinsured adults, effective immediately at VFA-enrolled locations.
2.) Vaccines for Children (VFC) coverage criteria for MMRV (ProQuad®) has been expanded to include ≥ 12 months to 12 years (no longer limited to ≥ 4 years through 12 years).
Press Releases
The North Carolina Immunization Program (NCIP) is excited to share an upcoming webinar, Building Confidence Before It Matters Most: A Data-Driven Approach to Communication, hosted by our partners at Neimand Collaborative. This session will benefit providers working at the intersection of public health, communications and policy.
We are excited to launch our new NCIP ServiceNow Portal. This portal is designed for providers currently participating in the North Carolina Immunization Program (NCIP) or the North Carolina Immunization Registry (NCIR). This portal brings all your essential links and tasks together in one convenient location for easy access.
This email shares the latest updates on the new North Carolina Immunization Registry (NCIR), a modernized system NC DHHS is implementing to support providers and partners. Below, you’ll find an overview of current progress, what to expect next, and how to prepare.
NCIP provider recertification is now open. Providers must complete recertification online through the 2026 North Carolina VFC Provider Agreement by April 25, 2026.
NCIP provider recertification is now open. Providers must complete recertification online through the 2026 North Carolina VFA Provider Agreement by April 25, 2026.
NCIP provider recertification is now open. Providers must complete recertification online through the 2026 North Carolina LHD Provider Agreement by April 25, 2026.
This email is to inform you that due to the continued RSV activity in the state, we are extending the administration and ordering of pediatric RSV prevention products Nirsevimab (Beyfortus®) and clesrovimab (ENFLONSIA™) for infants and toddlers through April 30, 2026.
For Local Health Departments Only: The North Carolina Immunization Program (NCIP) is exploring a one-time opportunity to share a limited quantity of MMR vaccines that expire June 5, 2026. These doses may be administered to any patient regardless of insurance status at no cost.
The purpose of this memorandum is to announce new regional consultant staff and share updated regional coverage maps.